These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15449704)

  • 1. Regulatory role of membrane-bound peptidases in the progression of gynecologic malignancies.
    Ino K; Shibata K; Kajiyama H; Kikkawa F; Mizutani S
    Biol Chem; 2004 Aug; 385(8):683-90. PubMed ID: 15449704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
    Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
    Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of the endothelin axis in ovarian tumor progression.
    Bagnato A; Spinella F; Rosanò L
    Endocr Relat Cancer; 2005 Dec; 12(4):761-72. PubMed ID: 16322321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid acyltransferase-beta is a prognostic marker and therapeutic target in gynecologic malignancies.
    Springett GM; Bonham L; Hummer A; Linkov I; Misra D; Ma C; Pezzoni G; Di Giovine S; Singer J; Kawasaki H; Spriggs D; Soslow R; Dupont J
    Cancer Res; 2005 Oct; 65(20):9415-25. PubMed ID: 16230405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral endopeptidase 24.11/CD10 suppresses progressive potential in ovarian carcinoma in vitro and in vivo.
    Kajiyama H; Shibata K; Terauchi M; Morita T; Ino K; Mizutani S; Kikkawa F
    Clin Cancer Res; 2005 Mar; 11(5):1798-808. PubMed ID: 15756002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of CD44v6 expression in gynecologic malignancies.
    Hong SC; Song JY; Lee JK; Lee NW; Kim SH; Yeom BW; Lee KW
    J Obstet Gynaecol Res; 2006 Aug; 32(4):379-86. PubMed ID: 16882263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer.
    Zivanovic O; Khoury-Collado F; Abu-Rustum NR; Gemignani ML
    Oncologist; 2009 Jul; 14(7):695-705. PubMed ID: 19608640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.
    Rak J; Klement P; Yu J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():135-8. PubMed ID: 16637463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of placental leucine aminopeptidase in gynecologic malignancy.
    Mizutani S; Shibata K; Kikkawa F; Hattori A; Tsujimoto M; Ishii M; Kobayashi H
    Expert Opin Ther Targets; 2007 Apr; 11(4):453-61. PubMed ID: 17373876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells.
    Fitzgerald JS; Tsareva SA; Poehlmann TG; Berod L; Meissner A; Corvinus FM; Wiederanders B; Pfitzner E; Markert UR; Friedrich K
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2284-96. PubMed ID: 16125646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteases in cancer progression].
    Flores-Reséndiz D; Castellanos-Juárez E; Benítez-Bribiesca L
    Gac Med Mex; 2009; 145(2):131-42. PubMed ID: 19518020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-mediated down-regulation of neutral endopeptidase (NEP; EC 3.4.24.11; CD10) on immature B lymphocytes by dexamethasone.
    Cupic B; Breljak D; Gabrilovac J
    Int J Mol Med; 2005 Jun; 15(6):1023-31. PubMed ID: 15870909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diagnostic evaluation of serum human telomerase reverse transcriptase mRNA as a novel tumor marker for gynecologic malignancies.
    Miura N; Kanamori Y; Takahashi M; Sato R; Tsukamoto T; Takahashi S; Harada T; Sano A; Shomori K; Harada T; Kigawa J; Ito H; Terakawa N; Hasegawa J; Shiota G
    Oncol Rep; 2007 Mar; 17(3):541-8. PubMed ID: 17273731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haymaker gene expression in malignant and normal gynecologic tissues.
    Borowsky ME; Das B; Axiotis CA; Malka ES; Abulafia O; Norin AJ
    J Histochem Cytochem; 2006 Jul; 54(7):753-61. PubMed ID: 16495475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.